Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/26/2026

1. ON
2. SYNA
3. SPY
4. MU
5. AAPL
6. VEON
7. DRI
8. NVDA
9. FDXF
10. NKE

Go back to Sana Biotechnology Announces Continued Positive Clinical Results Through 14 Months from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
(NASDAQ: SANA) Delayed: 3.38 +0.12 (3.68%)
Previous Close $3.26    52 Week High $ 
Open $3.23    52 Week Low $ 
Day High $3.55    P/E N/A 
Day Low $3.23    EPS $ 
Volume 2,378,007